结核分枝杆菌感染会导致癌症吗?呼吁转变对结核病和癌症的认识模式

IF 4.5 3区 医学 Q1 MICROBIOLOGY
Asrar A. Malik , Javaid A. Sheikh , Nasreen Z. Ehtesham , Subhash Hira , Seyed E. Hasnain
{"title":"结核分枝杆菌感染会导致癌症吗?呼吁转变对结核病和癌症的认识模式","authors":"Asrar A. Malik ,&nbsp;Javaid A. Sheikh ,&nbsp;Nasreen Z. Ehtesham ,&nbsp;Subhash Hira ,&nbsp;Seyed E. Hasnain","doi":"10.1016/j.ijmm.2022.151558","DOIUrl":null,"url":null,"abstract":"<div><p>Infections are known to cause tumours though more attributed to viruses. Strong epidemiological links suggest association between bacterial infections and cancers as exemplified by <em>Helicobacter pylori</em> and <em>Salmonella spp</em>. Infection with <em>Mycobacterium tuberculosis</em> (<em>M. tb</em>)<em>,</em> the etiological agent of tuberculosis (TB), has been reported to predispose patients to lung cancers and possibly in other organs as well. While this etiopathogenesis warrant inclusion of <em>M. tb</em> in IARC’s (International Agency for Research on Cancer) classified carcinogenic agents, the lack of well-defined literature and direct experimental studies have barred the research community from accepting the role of <em>M. tb</em> as a carcinogen. The background research, case studies, and experimental data extensively reviewed in Roy et al., 2021; provoke the debate for elucidating carcinogenic properties of <em>M. tb</em>. Moreover, proper, timely and correct diagnosis of both diseases (which often mimic each other) will save millions of lives that are misdiagnosed. In addition, use of Anti Tubercular therapy (ATT) in misdiagnosed non-TB patients contributes to drug resistance in population thereby severely impacting TB disease control measures. Research in this arena can further aid in saving billions of dollars by preventing the superfluous use of cancer drugs. In order to achieve these goals, it is imperative to identify the underlying mechanism of <em>M. tb</em> infection acting as major risk factor for cancer.</p></div>","PeriodicalId":50312,"journal":{"name":"International Journal of Medical Microbiology","volume":"312 5","pages":"Article 151558"},"PeriodicalIF":4.5000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S143842212200011X/pdfft?md5=b995fc8620dee04097add0d8dff22bac&pid=1-s2.0-S143842212200011X-main.pdf","citationCount":"7","resultStr":"{\"title\":\"Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in understanding TB and cancer\",\"authors\":\"Asrar A. Malik ,&nbsp;Javaid A. Sheikh ,&nbsp;Nasreen Z. Ehtesham ,&nbsp;Subhash Hira ,&nbsp;Seyed E. Hasnain\",\"doi\":\"10.1016/j.ijmm.2022.151558\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Infections are known to cause tumours though more attributed to viruses. Strong epidemiological links suggest association between bacterial infections and cancers as exemplified by <em>Helicobacter pylori</em> and <em>Salmonella spp</em>. Infection with <em>Mycobacterium tuberculosis</em> (<em>M. tb</em>)<em>,</em> the etiological agent of tuberculosis (TB), has been reported to predispose patients to lung cancers and possibly in other organs as well. While this etiopathogenesis warrant inclusion of <em>M. tb</em> in IARC’s (International Agency for Research on Cancer) classified carcinogenic agents, the lack of well-defined literature and direct experimental studies have barred the research community from accepting the role of <em>M. tb</em> as a carcinogen. The background research, case studies, and experimental data extensively reviewed in Roy et al., 2021; provoke the debate for elucidating carcinogenic properties of <em>M. tb</em>. Moreover, proper, timely and correct diagnosis of both diseases (which often mimic each other) will save millions of lives that are misdiagnosed. In addition, use of Anti Tubercular therapy (ATT) in misdiagnosed non-TB patients contributes to drug resistance in population thereby severely impacting TB disease control measures. Research in this arena can further aid in saving billions of dollars by preventing the superfluous use of cancer drugs. In order to achieve these goals, it is imperative to identify the underlying mechanism of <em>M. tb</em> infection acting as major risk factor for cancer.</p></div>\",\"PeriodicalId\":50312,\"journal\":{\"name\":\"International Journal of Medical Microbiology\",\"volume\":\"312 5\",\"pages\":\"Article 151558\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S143842212200011X/pdfft?md5=b995fc8620dee04097add0d8dff22bac&pid=1-s2.0-S143842212200011X-main.pdf\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Medical Microbiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S143842212200011X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Microbiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S143842212200011X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 7

摘要

众所周知,感染会导致肿瘤,尽管更多地归因于病毒。强大的流行病学联系表明细菌感染与癌症之间存在关联,例如幽门螺杆菌和沙门氏菌。据报道,结核病的病原结核分枝杆菌(M. tb)感染会使患者易患肺癌,也可能发生在其他器官。虽然这种发病机制有理由将结核分枝杆菌列入IARC(国际癌症研究机构)分类的致癌物中,但由于缺乏明确定义的文献和直接的实验研究,研究界无法接受结核分枝杆菌作为致癌物的作用。Roy等人,2021年广泛审查的背景研究、案例研究和实验数据;引发了关于阐明结核分枝杆菌致癌性质的争论。此外,正确、及时和正确地诊断这两种疾病(这两种疾病经常相互模仿)将挽救数百万被误诊的生命。此外,在误诊的非结核病患者中使用抗结核治疗(ATT)有助于人群耐药,从而严重影响结核病控制措施。这一领域的研究可以通过防止过量使用抗癌药物来进一步帮助节省数十亿美元。为了实现这些目标,必须确定结核分枝杆菌感染作为癌症主要危险因素的潜在机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in understanding TB and cancer

Infections are known to cause tumours though more attributed to viruses. Strong epidemiological links suggest association between bacterial infections and cancers as exemplified by Helicobacter pylori and Salmonella spp. Infection with Mycobacterium tuberculosis (M. tb), the etiological agent of tuberculosis (TB), has been reported to predispose patients to lung cancers and possibly in other organs as well. While this etiopathogenesis warrant inclusion of M. tb in IARC’s (International Agency for Research on Cancer) classified carcinogenic agents, the lack of well-defined literature and direct experimental studies have barred the research community from accepting the role of M. tb as a carcinogen. The background research, case studies, and experimental data extensively reviewed in Roy et al., 2021; provoke the debate for elucidating carcinogenic properties of M. tb. Moreover, proper, timely and correct diagnosis of both diseases (which often mimic each other) will save millions of lives that are misdiagnosed. In addition, use of Anti Tubercular therapy (ATT) in misdiagnosed non-TB patients contributes to drug resistance in population thereby severely impacting TB disease control measures. Research in this arena can further aid in saving billions of dollars by preventing the superfluous use of cancer drugs. In order to achieve these goals, it is imperative to identify the underlying mechanism of M. tb infection acting as major risk factor for cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.70
自引率
0.00%
发文量
18
审稿时长
45 days
期刊介绍: Pathogen genome sequencing projects have provided a wealth of data that need to be set in context to pathogenicity and the outcome of infections. In addition, the interplay between a pathogen and its host cell has become increasingly important to understand and interfere with diseases caused by microbial pathogens. IJMM meets these needs by focussing on genome and proteome analyses, studies dealing with the molecular mechanisms of pathogenicity and the evolution of pathogenic agents, the interactions between pathogens and host cells ("cellular microbiology"), and molecular epidemiology. To help the reader keeping up with the rapidly evolving new findings in the field of medical microbiology, IJMM publishes original articles, case studies and topical, state-of-the-art mini-reviews in a well balanced fashion. All articles are strictly peer-reviewed. Important topics are reinforced by 2 special issues per year dedicated to a particular theme. Finally, at irregular intervals, current opinions on recent or future developments in medical microbiology are presented in an editorial section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信